18 Biggest Mid-Day Gainers For Friday

Mirati Therapeutics, Inc. MRTX shares surged 97.9 percent to $9.40 after the company presented positive preliminary data from sitravatinib studies.
Abeona Therapeutics Inc ABEO shares rose 19.8 percent to $16.77. RBC Capital initiated coverage on Abeona Therapeutics with an Outperform rating and $23 price target.
Arrowhead Pharmaceuticals Inc ARWR shares gained 16.5 percent to $3.25.
Helios and Matheson Analytics Inc HMNY shares surged 12.4 percent to $2.96.
Champions Oncology Inc CSBR jumped 11.6 percent to $ 3.59. Champions Biotech reported Q1 loss from operations of $619,000, on revenue of $5 million.
The Stars Group Inc. TSG shares gained 10.5 percent to $19.27 after the company raised its FY2017 guidance.
LightPath Technologies, Inc. LPTH gained 9.5 percent to $2.64. LightPath Technologies reported Q4 net income of $6.4 million, up from $331,000 in the year-ago quarter. Its revenue climbed 90 percent to $9.0 million.
Daqo New Energy Corp DQ shares climbed 8.5 percent to $28.88.
Veritone Inc VERI shares rose 7.8 percent to $30.75.
CRH Medical Corp CRHM shares climbed 7 percent to $3.05.
Intercept Pharmaceuticals Inc ICPT gained 5.8 percent to $92.50. RBC Capital initiated coverage of Intercept Pharmaceuticals with an Outperform rating and $244 price target.
P & F Industries, Inc. PFIN rose 5.7 percent to $ 7.45 after the company reported the purchase of the assets of NUMATX.
Athenex Inc ATNX gained 5.5 percent to $17.28. RBC Capital initiated coverage of Athenex with an Outperform rating and $35 price target.
First Solar, Inc. FSLR shares gained 5.2 percent to $50.93. Deutsche Bank upgraded First Solar from Hold to Buy.
Resolute Energy Corp REN rose 5 percent to $ 28.95 as the company agreed to sell Aneth Field for up to $195 million.
Marinus Pharmaceuticals Inc MRNS shares climbed 4.3 percent to $ 4.18. Marinus Pharma priced its 9.33 million share offering at $3.75 per share.
Prothena Corporation PLC PRTA gained 3.8 percent to $65.14. RBC Capital initiated coverage of Prothena with an Outperform rating and $87 price target.
Oclaro Inc OCLR rose 3.1 percent to $9.03. Raymond James initiated coverage on Oclaro with a Strong Buy rating and a $12.00 price target.